Bio/Pharma News

Dec 05, 2018
By Pharmaceutical Technology Editors
AbbVie will grant Pfizer license to launch a biosimilar to AbbVie’s Humira worldwide.
Nov 30, 2018
By Pharmaceutical Technology Editors
The acquisition will give Genentech full rights to Jecure’s preclinical portfolio of NLRP3 inhibitors.
Nov 27, 2018
By Pharmaceutical Technology Editors
The agency has approved two new chemical entities, Daurismo (glasdegib) from Pfizer, and Vitrakvi (larotrectinib) from Loxo Oncology, for treating cancers.
Nov 20, 2018
By Pharmaceutical Technology Editors
The vaccine producer announced an expansion to its Holly Springs, NC, manufacturing facility where it will increase production of its cell-based quadrivalent influenza vaccine.
Nov 19, 2018
By Pharmaceutical Technology Editors
AstraZeneca is set to divest US rights to Synagis (palivizumab) to Swedish Orphan Biovitrum (Sobi), a biopharmaceutical company focused on rare diseases, for $1.5 billion.
Nov 16, 2018
By Pharmaceutical Technology Editors
The companies will develop AMG 714, a novel anti-IL-15 monoclonal antibody, for the treatment of gluten-free diet non-responsive celiac disease in a collaboration worth $170 million.
Nov 14, 2018
By Pharmaceutical Technology Editors
The companies will develop treatments for a range of neurological and inflammatory diseases.
Nov 08, 2018
By Pharmaceutical Technology Editors
AbbVie will grant Momenta license to launch a biosimilar to AbbVie’s Humira.
Nov 08, 2018
By Pharmaceutical Technology Editors
The decision follows an FDA request for additional information to complement the company’s submission for biosimilar rituximab.
Nov 07, 2018
By Pharmaceutical Technology Editors
The International Society for Pharmaceutical Engineering (ISPE) named Shire as the ISPE 2018 Facility of the Year Awards Overall Winner for a facility integration project in Los Angeles, CA.
native1_300x100
lorem ipsum